• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA倍体分析与miR-21或miR-24联合用于恶性胸腔积液的筛查

Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.

作者信息

Liu Chongmei, Huang Liuyan, Zhang Xuechun, Yang Juan

机构信息

Department of Pathology, Yueyang Second People's Hospital, Yueyang, Hunan, China.

Graduate School of The University of South China, Hengyang, Hunan, China.

出版信息

Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):376-381. doi: 10.1093/icvts/ivx327.

DOI:10.1093/icvts/ivx327
PMID:29069463
Abstract

OBJECTIVES

The study aimed to assess the combination of DNA ploidy analysis (DPA) and the expression of microRNA-21 (miR-21) or microRNA-24 (miR-24) in the detection of malignant pleural effusion (MPE).

METHODS

In this prospective research, a total of 40 samples (20 benign and 20 malignant effusions), flexural effusion exfoliated cells and cell-free miR-21 and miR-24 were collected. DPA and exfoliative cytology examinations were conducted to diagnose flexural effusion exfoliated cells. Quantitative reverse transcriptase polymerase chain reaction was carried out to measure the expressions of miR-21 and miR-24. Receiver operating characteristic curve and the area under the curve were applied to evaluate the accuracy rate of different diagnostic approaches on MPE.

RESULTS

In the MPE group, DPA demonstrated a higher rate of accuracy in MPE diagnosis than exfoliative cytology. The expressions of miR-21 and miR-24 were significantly higher in MPE than in benign pleural effusion (P < 0.05). Furthermore, area under the curve, sensitivity and specificity were 0.942, 95% and 90% for the combination of miR-21 and DPA and 0.973, 100% and 80% for the union of miR-24 and DPA, respectively, representing a significant improvement in both accuracy and sensitivity. Therefore, the combination of DPA and miR-21 or miR-24 appears to be a better biomarker for discriminating MPE from benign pleural effusion.

CONCLUSIONS

The combination of DPA and miR-21 or miR-24 may function as a promising diagnostic tool of MPE.

REGISTRATION NUMBER

ChiCTR-TRC-14004719.

摘要

目的

本研究旨在评估DNA倍体分析(DPA)与微小RNA-21(miR-21)或微小RNA-24(miR-24)的表达在恶性胸腔积液(MPE)检测中的联合应用。

方法

在这项前瞻性研究中,共收集了40份样本(20份良性积液和20份恶性积液)、胸腔积液脱落细胞以及游离的miR-21和miR-24。进行DPA和脱落细胞学检查以诊断胸腔积液脱落细胞。采用定量逆转录聚合酶链反应来测量miR-21和miR-24的表达。应用受试者工作特征曲线及曲线下面积来评估不同诊断方法对MPE的准确率。

结果

在MPE组中,DPA在MPE诊断中的准确率高于脱落细胞学。MPE中miR-21和miR-24的表达显著高于良性胸腔积液(P<0.05)。此外,miR-21与DPA联合的曲线下面积、敏感性和特异性分别为0.942、95%和90%,miR-24与DPA联合的分别为0.973、100%和80%,在准确性和敏感性方面均有显著提高。因此,DPA与miR-21或miR-24联合似乎是鉴别MPE与良性胸腔积液的更好生物标志物。

结论

DPA与miR-21或miR-2联合可能是一种有前景的MPE诊断工具。

注册号

ChiCTR-TRC-14004719。

相似文献

1
Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.DNA倍体分析与miR-21或miR-24联合用于恶性胸腔积液的筛查
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):376-381. doi: 10.1093/icvts/ivx327.
2
Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.细胞游离 miR-198 下调作为肺腺癌相关恶性胸腔积液的诊断生物标志物。
Int J Cancer. 2013 Aug 1;133(3):645-52. doi: 10.1002/ijc.28054. Epub 2013 Feb 25.
3
[The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].[B7-H4与癌胚抗原在诊断良恶性胸腔积液中的价值]
Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):524-527. doi: 10.3760/cma.j.issn.0253-3766.2017.07.009.
4
Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.鉴别良、恶性胸腔积液中差异表达的 microRNAs。
Hereditas. 2020 Feb 26;157(1):6. doi: 10.1186/s41065-020-00119-z.
5
Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.肺腺癌相关恶性胸腔积液患者的外泌体微小RNA表达谱分析
Anticancer Res. 2018 Dec;38(12):6707-6714. doi: 10.21873/anticanres.13039.
6
Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.内皮抑素对恶性胸腔积液的诊断准确性:一项临床研究与荟萃分析。
Postgrad Med. 2015 Jun;127(5):529-34. doi: 10.1080/00325481.2015.1048180. Epub 2015 May 15.
7
Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.游离DNA甲基化分析作为胸腔积液恶性肿瘤的标志物
Sci Rep. 2024 Feb 5;14(1):2939. doi: 10.1038/s41598-024-53132-x.
8
Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.评估血清和胸腔积液中的一组 microRNA 用于良恶性胸腔积液的鉴别诊断。
Cancer Biomark. 2022;33(1):71-82. doi: 10.3233/CBM-210090.
9
Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.神经元特异性烯醇化酶对恶性胸腔积液的诊断是否有用?一项验证研究和荟萃分析的证据。
BMC Cancer. 2017 Aug 30;17(1):590. doi: 10.1186/s12885-017-3572-2.
10
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.胸腔积液无细胞游离 DNA 完整性指数鉴别包括间皮瘤在内的细胞学阴性恶性胸腔积液。
BMC Cancer. 2012 Sep 25;12:428. doi: 10.1186/1471-2407-12-428.

引用本文的文献

1
[Expression of circRNA_051778 in Lung Adenocarcinoma-Associated Malignant and Tuberculous Pleural Effusions and Its Clinical Significance].[环状RNA_051778在肺腺癌相关恶性及结核性胸腔积液中的表达及其临床意义]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1254-1263. doi: 10.12182/20240960302.
2
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.恶性胸腔积液诊断中的胸膜生物标志物:一项叙述性综述
Transl Lung Cancer Res. 2021 Mar;10(3):1557-1570. doi: 10.21037/tlcr-20-1111.
3
A Comparative Study of Liquid-Based Cytology and DNA Image Cytometry in the Diagnosis of Serous Effusion.
液基细胞学与 DNA 图像细胞仪在浆膜腔积液诊断中的对比研究
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820942298. doi: 10.1177/1533033820942298.